insider24.ch
Back to the feed

Shareholding disclosure

OrbiMed Genesis Master Fund, L.P., c/o OrbiMed Advisors LLC

inSanthera Pharmaceuticals Holding AG

Declared position

6.5%

Threshold

Crossed upwards

Timeline

Published

18.05.2021

Transaction

07.05.2021

Voting rights breakdown

Voting rights acquired6.5%
Voting rights sold0%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAL5H00011

Beneficial owner

OrbiMed Genesis Master Fund, L.P., c/o OrbiMed Advisors LLC

Declared address

OrbiMed Genesis Master Fund, L.P., c/o OrbiMed Advisors LLC, New York, NY 10022

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open